Novartis and Boston Scientific Fall While Intel Gains

Novartis shares dropped following its third clinical trial failure in a week, while Boston Scientific declined after a cybersecurity incident disrupted product shipments and forced lowered financial guidance. Meanwhile, Intel stock climbed on reports of planned computer chip price hikes next month, according to Bloomberg data highlighting varied market movements across the pharmaceutical, medical device, and technology sectors.